Merck

ZERBAXA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ZERBAXA – J0695

Manufacturer:

Merck

Name:

ZERBAXA

HCPCS Code Descriptor:

Injection, ceftolozane 50 mg and tazobactam 25 mg

Category:

J Code

HCPCS:

J0695

NDC(s):

67919-0030-01

Primary Type:

Antibiotic

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ZERBAXA is an Antibiotic drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J0695 is aligned to the drug ZERBAXA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/16

HCPCS Effective Date:

1/1/16

HCPCS Short Description:

Inj ceftolozane tazobactam

Billing and Coding Guide:

https://www.merckconnect.com/static/pdf/zerbaxa-dosing-billing-guide.pdf

Patient Assistance:

Not Found